SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-044029
Filing Date
2021-08-12
Accepted
2021-08-12 16:46:37
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 apvo-s3.htm S-3 347212
2 EX-5.1 apvo-ex51_7.htm EX-5.1 9570
3 EX-23.1 apvo-ex231_11.htm EX-23.1 2685
4 EX-23.2 apvo-ex232_113.htm EX-23.2 2737
5 GRAPHIC ggczyo3xdemj000001.jpg GRAPHIC 4497
  Complete submission text file 0001564590-21-044029.txt   369525
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258758 | Film No.: 211168308
SIC: 2834 Pharmaceutical Preparations